Abstract
Purpose To assess the health-related quality of life (HRQOL) of oral cancer patients who receive radiotherapy (RT) with or without chemotherapy and the changes in HRQOL.
Patients and Methods A prospective study was conducted among oral cancer patients who receive RT with or without chemotherapy. Two European Organization for the Research and Treatment of Cancer Quality of Life Questionnaires: EORTC QLQ-C30 and EORTC QLQ-H&N35, were used to assess HRQOL before RT, during the last week of RT and three months after RT. High scores of symptom domains and items indicate low HRQOL and wise versa for functional and ‘Global health status’ domains.
Results Ninety oral cancer patients were included. The majority of the sample were males (88%) and 68% were aged 50-69. The median scores of all the domains and items in EORTC QLQ-H&N35 and symptom domains and items in EORTC QLQ-C30 were higher during the last week of RT compared to the baseline. The functional domains of EORTC QLQ-C30 showed the highest median values (100.0) at baseline but much less values (<66.7) during last week of RT. Except for ‘Appetite loss’ item, all the symptom domains and items scores were lower at three months after RT than the median scores during last week of RT. Statistically significant differences were observed in almost all the changes in HRQOL between three-time frames (p<0.05).
Conclusions HRQOL of oral cancer patients declined due to RT from baseline to the last week of RT and improved three months after RT from last week of RT but had not returned to the baseline level.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval to conduct the study was granted from the Ethics Review Committee of Faculty of Medicine, University of Colombo, Sri Lanka (EC-15-200).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
